Loading clinical trials...
Loading clinical trials...
Effectiveness of Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Aortic and Mitral Valvular Atrial Fibrillation Patients
Conditions
Interventions
Dabigatran
Acetylsalicylic acid
+1 more
Locations
1
South Korea
Asan Medical Center
Seoul, South Korea
Start Date
December 1, 2016
Primary Completion Date
October 1, 2020
Completion Date
October 1, 2020
Last Updated
January 13, 2021
NCT05009797
NCT07421076
NCT06500988
NCT07490808
NCT07429214
NCT05976685
Lead Sponsor
Asan Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions